ConductScience.org, home

Trial · NCT01355068

Participant flow18

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
First Intervention PeriodSTARTEDEpanutin Infatabs 50 mg First, Then Dilantin Infatabs 50 mg13
First Intervention PeriodSTARTEDDilantin Infatabs 50 mg First, Then Epanutin Infatabs 50 mg13
First Intervention PeriodCOMPLETEDEpanutin Infatabs 50 mg First, Then Dilantin Infatabs 50 mg13
First Intervention PeriodCOMPLETEDDilantin Infatabs 50 mg First, Then Epanutin Infatabs 50 mg11
First Intervention PeriodNOT COMPLETEDEpanutin Infatabs 50 mg First, Then Dilantin Infatabs 50 mg0
First Intervention PeriodNOT COMPLETEDDilantin Infatabs 50 mg First, Then Epanutin Infatabs 50 mg2
Washout Period (at Least 7 Days)STARTEDEpanutin Infatabs 50 mg First, Then Dilantin Infatabs 50 mg13
Washout Period (at Least 7 Days)STARTEDDilantin Infatabs 50 mg First, Then Epanutin Infatabs 50 mg11
Washout Period (at Least 7 Days)COMPLETEDEpanutin Infatabs 50 mg First, Then Dilantin Infatabs 50 mg13
Washout Period (at Least 7 Days)COMPLETEDDilantin Infatabs 50 mg First, Then Epanutin Infatabs 50 mg11
Washout Period (at Least 7 Days)NOT COMPLETEDEpanutin Infatabs 50 mg First, Then Dilantin Infatabs 50 mg0
Washout Period (at Least 7 Days)NOT COMPLETEDDilantin Infatabs 50 mg First, Then Epanutin Infatabs 50 mg0
Second Intervention PeriodSTARTEDEpanutin Infatabs 50 mg First, Then Dilantin Infatabs 50 mg13
Second Intervention PeriodSTARTEDDilantin Infatabs 50 mg First, Then Epanutin Infatabs 50 mg11
Second Intervention PeriodCOMPLETEDEpanutin Infatabs 50 mg First, Then Dilantin Infatabs 50 mg13
Second Intervention PeriodCOMPLETEDDilantin Infatabs 50 mg First, Then Epanutin Infatabs 50 mg11
Second Intervention PeriodNOT COMPLETEDEpanutin Infatabs 50 mg First, Then Dilantin Infatabs 50 mg0
Second Intervention PeriodNOT COMPLETEDDilantin Infatabs 50 mg First, Then Epanutin Infatabs 50 mg0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01355068/flow